EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling the dangerous duet between cancer cell plasticity and drug resistance

Namrata Chatterjee, Bhavana Pulipaka, Ayalur Raghu Subbalakshmi, Mohit Kumar Jolly, Radhika Nair

Computational and Systems Oncology · 2023-09 · 3 (3)

DOI: 10.1002/cso2.1051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Computational and Systems Oncology, online erschienen am 15.08.2023. Verfasst von Namrata Chatterjee und 4 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cell plasticity is the ability of tumor cells to switch phenotypes and is one of the predominant requisites of cancer cells capable of undergoing metastasis. Cancer cell plasticity is also recognized as one of the major contributors to intratumoral heterogeneity, a critical factor underlying the progression of malignant tumors, which is known to modify tumor response and induce resistance against various modes of therapy, thus posing a barrier to efficient cancer management. Cancer cell plasticity is acquired by the subversion of cell signaling pathways like mitogen‐activated protein kinase pathway, phosphoinositide‐3‐kinase, signal transducer and activator of transcription 3, Wnt, Hedgehog and Notch as well as cellular programs such as epithelial to mesenchymal transition and phenotypic plasticity. This complex phenomenon has been studied in many cancer types like pancreatic cancer, colon cancer and breast cancer. This review will explore the current understanding we have in breast cancer on the intrinsic molecular mechanisms of cancer cell plasticity and the resistance to various types of cancer therapy that arise as a result of plasticity. We conclude by exploring the potential novel therapies that specifically target the pathways leading to plasticity and can be leveraged to treat patients living with the disease.

Zitieren

APA

Chatterjee, N., Pulipaka, B., Subbalakshmi, A. R., Jolly, M. K., & Nair, R. (2023). Unraveling the dangerous duet between cancer cell plasticity and drug resistance. Computational and Systems Oncology, 3(3). https://doi.org/10.1002/cso2.1051

Vancouver

Chatterjee N, Pulipaka B, Subbalakshmi AR, Jolly MK, Nair R. Unraveling the dangerous duet between cancer cell plasticity and drug resistance. Computational and Systems Oncology. 2023;3(3). doi:10.1002/cso2.1051

BibTeX
@article{Chatterjee2023,
  author = {Chatterjee, Namrata and Pulipaka, Bhavana and Subbalakshmi, Ayalur Raghu and Jolly, Mohit Kumar and Nair, Radhika},
  title = {Unraveling the dangerous duet between cancer cell plasticity and drug resistance},
  journal = {Computational and Systems Oncology},
  year = {2023},
  volume = {3},
  number = {3},
  doi = {10.1002/cso2.1051}
}
Kostenlos starten →